Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: The FIDELITY Analysis - Rossing, P; Anker, S D; Filippatos, G; FIDELIO-DKD and FIGARO-DKD Investigators (Diabetes Care, 2022)
et al.